Medical case reports suggest that cannabinoids extracted from Cannabis sativa have
therapeutic effects; however, the therapeutic employment is limited due to the psychotropic …

Hepatitis C virus (HCV) infection is an important cause of cirrhosis and hepatocellular
carcinoma (HCC) worldwide. 1 It is also a common cause of chronic liver disease in the …

Funding for the development of this Practice Guidance was provided by the American
Association for the Study of Liver Diseases. MV was supported by aAQ19 Patient-Centered …

Liver disease is the twelfth commonest cause of mortality in adults in the United States,
resulting in 34,000 deaths annually from cirrhosis. 7 In addition, the rising incidence of HCC …

In high income countries, the majority of new and existing hepatitis C virus (HCV) infections
occur among people who inject drugs (PWID). In many low and middle income countries …

Background Cannabinoids are used by patients with inflammatory bowel disease (IBD) to
alleviate their symptoms. Little is known on patient motivation, benefit, or risks of this …

Medical cannabis use is increasing worldwide. Clinicians are commonly asked by patients
to provide guidance on its safety and efficacy. Although there has been an increase in …

The hepatic complications of chronic hepatitis C (CHC) usually occur only after progression
to cirrhosis has taken place. Progression to cirrhosis, however, is extremely variable and …

The marijuana plant Cannabis sativa and its derivatives, cannabinoids, have grown
increasingly popular as a potential therapy for inflammatory bowel disease (IBD). Studies …

Cannabis sativa, a subspecies of the Cannabis plant, contains aromatic hydrocarbon
compounds called cannabinoids.∆ 9-Tetrahydrocannabinol is the most abundant …